This article needs additional citations for verification .(October 2016) |
The American Parkinson Disease Association (APDA) is a grassroots advocacy organization for sufferers of Parkinson's disease and their families.
Founded in 1961, the APDA aims to "ease the burden" for Americans with Parkinson's disease, as well as for their families, through nationwide Information and Referral Centers and support groups. The APDA also pursues efforts to find a cure for Parkinson's, as they fund centers for advanced research and award grants to researchers as means to fund them. [1]
Since its founding, the APDA has reportedly raised and invested more than $87 million to fund research, to provide patient services and education, and to elevate public awareness. [1]
Michael Andrew Fox, known professionally as Michael J. Fox, is a Canadian-American retired actor. Beginning his career in the 1970s, he first rose to prominence for portraying Alex P. Keaton on the NBC sitcom Family Ties (1982–1989). Fox achieved further recognition as protagonist Marty McFly in the Back to the Future film trilogy (1985–1990). The trilogy's critical and commercial success led to Fox headlining several films throughout the 1980s and 1990s, including The Secret of My Success (1987), Casualties of War (1989), and The Frighteners (1996). He returned to television on the ABC sitcom Spin City, where he portrayed the lead role of Mike Flaherty from 1996 to 2000.
APDA may refer to:
Parkinson's UK is a Parkinson's research and support charity in the United Kingdom. In April 2010, the Parkinson's Disease Society changed its name to become Parkinson's UK. Its aims are to improve the quality of life for people affected by Parkinson's and find a cure for the condition.
The Lou Ruvo Center for Brain Health (LRCBH), officially the Cleveland Clinic Lou Ruvo Center for Brain Health, opened on May 21, 2010, in Las Vegas, Nevada. It is operated by the Cleveland Clinic and was designed by Frank Gehry.
The Alliance for Aging Research is a non-profit organization based in Washington, D.C., that promotes medical research to improve the human experience of aging. Founded in 1986 by Daniel Perry, the Alliance also advocates and implements health education for consumers and health professionals.
The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease (PD) through funded research and ensuring the development of improved therapies for those living with Parkinson's today. Established by Michael J. Fox in 2000, the Foundation has since become the largest non-profit funder of Parkinson's disease research in the world, having funded more than $1 billion in research funding to date. In 2010, the Foundation launched the first large-scale clinical study on evolution biomarkers of the disease at a cost of $45 million over five years. The organization hosts the Fox Trial Finder, which is a website for presenting clinical trials in Parkinson's disease clinical research.
Van Andel Institute(VAI) is a 501(c)(3) nonprofit biomedical research and science education organization in Grand Rapids, Michigan. VAI was founded by Jay and Betty Van Andel in 1996 and comprises four divisions: Van Andel Research Institute (VARI), Van Andel Education Institute (VAEI), Van Andel Institute Graduate School (VAIGS), and Purple Community.
The Ronald and Nancy Reagan Research Institute, an affiliate of the National Alzheimer's Association in Chicago, Illinois, is an initiative founded by former United States President Ronald Reagan and First Lady Nancy Reagan to accelerate the progress of Alzheimer's disease research. The center was dedicated in 1995.
The Davis Phinney Foundation is a non-profit with a mission to help people with Parkinson's live well with the disease. It was founded in 2004 by Davis Phinney, a former professional road bicycle racer and Olympic medal winner. Today, Davis is an inspirational figure in the cycling community and people living with Parkinson's.
John Quinn Trojanowski, M.D., Ph.D. is an academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.
Parkinson's disease (PD), or simply Parkinson's, is a long-term degenerative disorder of the central nervous system that mainly affects the motor system. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. The most obvious early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Cognitive and behavioral problems may also occur with depression, anxiety, and apathy occurring in many people with PD. Parkinson's disease dementia becomes common in the advanced stages of the disease. Those with Parkinson's can also have problems with their sleep and sensory systems. The motor symptoms of the disease result from the death of cells in the substantia nigra, a region of the midbrain, leading to a dopamine deficit. The cause of this cell death is poorly understood, but involves the build-up of misfolded proteins into Lewy bodies in the neurons. Collectively, the main motor symptoms are also known as parkinsonism or a parkinsonian syndrome.
Parkinson's disease clinical research is any study intended to help answer questions about etiology, diagnostic approaches or new treatments by studying their effects on human subjects. Clinical trials are designed and conducted by scientists and medical experts, who invite participants to undergo testing new vaccines, therapies, or treatments.
Andrew John Lees is Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square, London and University College London. In 2011 he was named as the world's most highly cited Parkinson's disease researcher.
The Yale Debate Association (YDA) is Yale University's only competitive intercollegiate debate team. Founded in 1908, it is the most prolific winner of the American Parliamentary Debate Association's Club of the Year award. The YDA was also the first American team to win and have the top speaker at the modern World Championships. Currently, the YDA is the fourth-ranked collegiate debate society in the world, and the highest in North America.
Joseph Jankovic is an American neurologist who is a professor in neurology at Baylor College of Medicine in Houston, Texas. He is the Distinguished Chair in Movement Disorders and founder and director of the Parkinson's Disease Center and Movement Disorders Clinic.
"On Sight" is a song by American rapper Kanye West from his sixth studio album, Yeezus (2013). It was produced by West and Daft Punk, with additional production by Benji B and Mike Dean. The song includes an electronic sound that was mainly contributed by Daft Punk, who were the first people West became involved with for the album. The song itself was first heard when performed live by West at the Governors Ball Music Festival in 2013.
Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.
Lawrence E. Golub is an American entrepreneur, philanthropist, and business executive. He is the CEO of Golub Capital, a credit asset management company he founded in 1994. Prior to Golub Capital, he had management careers with Bankers Trust Company and Allen & Company. Golub sits on the board of numerous organizations, including American Repertory Theater and Harvard University's JD-MBA Alumni Association. He is one of three private members of the Financial Control Board of the State of New York.
The Parkinson’s Foundation is a national organization whose mission is to make life better for people with Parkinson’s disease by improving care and advancing research toward a cure. The Parkinson’s Foundation was established in 2016 through the merger of the National Parkinson Foundation and the Parkinson’s Disease Foundation. It has offices in Miami and New York City.
California Proposition 14 is a citizen-initiated ballot measure that appeared on the ballot in the 2020 California elections, for November 3, 2020. It authorizes state bonds to be issued worth $5.5 billion, which will fund the California Institute for Regenerative Medicine (CIRM), which serves as the state's center for stem cell research, and enable it to continue its operations. This measure passed with 51% of the vote.